GO:0034338 short-chain carboxylesterase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034338 short-chain carboxylesterase activity is a molecular function defined as catalysis of the hydrolysis of a carboxylic ester into an alcohol and a carboxylic anion, where the carboxylic chain has 8 or fewer carbon atoms.
• The term is synonymous with butyrate esterase, butyryl esterase, methylbutyrase, methylbutyrate esterase, monobutyrase, propionyl esterase and short-chain esterase activity, reflecting its preference for short-chain acyl substrates.
• Enzymes with this activity belong to the serine hydrolase superfamily and use a catalytic triad to cleave ester bonds in short-chain esters such as p-nitrophenyl butyrate.
• Short-chain carboxylesterase activity is found in bacteria, fungi, plants, insects and mammals, and is studied for applications in ester synthesis, pollutant degradation and prodrug activation.
• Substrate specificity is restricted to short-chain acid esters, distinguishing this activity from long-chain lipase and phospholipase activities.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to establish causal roles of candidate short-chain carboxylesterase genes in physiology and disease.
Description
GO:0034338 short-chain carboxylesterase activity is a molecular function that catalyzes the hydrolysis of carboxylic esters into an alcohol and a carboxylic anion, with a strict preference for acyl chains of eight or fewer carbon atoms. This activity is widely distributed across all kingdoms of life and is encoded by serine hydrolases that share a common alpha/beta hydrolase fold and a catalytic triad. Because short-chain esters are common intermediates in lipid metabolism, xenobiotic detoxification and industrial biotransformations, enzymes with this activity are of broad interest to biochemists, microbiologists and drug discovery researchers. The term is often confused with general carboxylesterase or lipase activity, but its defining feature is the short-chain length of the carboxylic acid substrate. This substrate restriction has practical consequences: short-chain carboxylesterases are used in the food and flavor industry, in the degradation of synthetic esters, and as reporters in high-throughput enzyme assays using p-nitrophenyl esters. In mammals, related esterases contribute to the metabolism of endogenous lipids and xenobiotics, and their dysfunction has been linked to metabolic and inflammatory conditions. For researchers, GO:0034338 provides a precise functional annotation that can be used to classify newly discovered enzymes, to design substrate-specific inhibitors, and to interpret omics data. This article summarizes the definition, mechanism, key genes, disease relevance and experimental methods for studying short-chain carboxylesterase activity, with all factual claims supported by the cited literature.
short-chain carboxylesterase activity At A Glance
| GO ID | GO:0034338 |
|---|---|
| GO term | short-chain carboxylesterase activity |
| Ontology | molecular_function |
| Synonym | butyrate esterase activity; butyryl esterase activity; methylbutyrase activity; methylbutyrate esterase activity; monobutyrase activity; propionyl esterase activity; short-chain esterase activity |
| Major function | Hydrolysis of carboxylic esters with acyl chains of 8 or fewer carbon atoms into an alcohol and a carboxylic anion |
| Substrate preference | Short-chain p-nitrophenyl esters such as p-nitrophenyl butyrate |
| Catalytic residues | Serine hydrolase catalytic triad (Ser-His-Asp/Glu) |
| Cellular context | Cytosol, lysosome, secreted and membrane-associated forms depending on the enzyme |
| Representative enzymes | MarCE marine carboxylesterase, artificial self-assembling peptide with carboxylesterase activity |
What Is GO:0034338?
In simple terms, GO:0034338 describes an enzyme that cuts ester bonds in small fat-like molecules. The official QuickGO definition states: Catalysis of the reaction: a carboxylic ester + H2O = an alcohol + a carboxylic anion, where the carboxylic chain has 8 or fewer carbon atoms. This means the enzyme accepts ester substrates whose acyl group is short (for example, butyrate, propionate or acetate esters) and releases the corresponding alcohol and carboxylic acid anion. The activity is classified under molecular_function and is distinguished from long-chain lipase and phospholipase activities by its substrate chain-length preference.
Why Is short-chain carboxylesterase activity Important in Cell Biology?
Short-chain carboxylesterase activity is important because it controls the turnover of short-chain esters that serve as signaling molecules, metabolic intermediates and industrial substrates. In biotechnology, enzymes with this activity are used for ester synthesis and degradation, including the breakdown of synthetic esters and pollutants. In medicine, related esterases influence drug metabolism and lipid signaling, and their dysregulation has been associated with metabolic and inflammatory diseases. Understanding GO:0034338 therefore bridges basic enzymology, microbial ecology and translational research.
• Provides a precise functional annotation for classifying serine hydrolases that act on short-chain esters.
• Enables substrate-specific assays using p-nitrophenyl butyrate and related chromogenic esters.
• Supports industrial biocatalysis for ester synthesis, flavor production and polyester degradation.
• Contributes to xenobiotic and drug metabolism through hydrolysis of ester-containing compounds.
• Links to lipid signaling pathways that influence inflammation and metabolic homeostasis.
• Offers a target for engineering enzymes with tailored chain-length specificity.
• Helps interpret metagenomic and metatranscriptomic data from environmental microbiomes.
• Guides CRISPR-based functional studies of candidate esterase genes in disease models.
Molecular Mechanism of short-chain carboxylesterase activity
Substrate recognition and binding
In simple terms: The enzyme first grabs the short-chain ester substrate and positions it for cutting.
Short-chain carboxylesterases recognize substrates through an acyl-binding pocket that is sterically restricted, allowing only carboxylic chains of eight or fewer carbons to enter. This restriction distinguishes them from lipases that prefer long-chain triglycerides. The artificial self-assembling peptide with carboxylesterase activity shows that even minimal active-site architectures can achieve this substrate specificity.
Catalytic triad and hydrolysis
In simple terms: A trio of amino acids in the enzyme active site performs the actual chemical cut.
The catalytic mechanism follows the classic serine hydrolase pathway: a serine nucleophile attacks the ester carbonyl, forming an acyl-enzyme intermediate, which is then hydrolyzed by water to release the alcohol and carboxylic anion. The triad typically consists of Ser-His-Asp/Glu, and mutation of the catalytic serine abolishes activity. MarCE, a marine carboxylesterase, exemplifies this mechanism with synthetic ester-degrading activity.
Cofactors and metal dependence
In simple terms: Some of these enzymes need helper molecules or metals to work, while others do not.
Most short-chain carboxylesterases are metal-independent serine hydrolases, but some family members require calcium or other divalent cations for stability or activity. The artificial peptide enzyme functions without metals, demonstrating that the catalytic machinery alone can support hydrolysis. Phospholipase A2 enzymes, which are not classified under GO:0034338, illustrate a different metal-dependent mechanism for ester cleavage.
Regulation and inhibition
In simple terms: The activity can be turned up or down by cellular signals and chemical inhibitors.
Short-chain carboxylesterase activity is regulated at the level of gene expression, post-translational modification and substrate availability. Serine hydrolase inhibitors such as organophosphates and fluorophosphonates covalently modify the catalytic serine and block activity. In microbial systems, expression of carboxylesterase genes is often induced by the presence of ester substrates or environmental stress.
Substrate specificity and chain-length discrimination
In simple terms: The enzyme chooses short fats over long fats because its pocket is too small for long chains.
The acyl-binding pocket of short-chain carboxylesterases is shallow and narrow, which physically excludes long-chain substrates. This is why the artificial peptide reported by Liu et al. is active only on short-chain p-nitrophenyl esters. In contrast, lipases that accept long-chain triglycerides have a larger hydrophobic tunnel and often require interfacial activation.
Key Genes Involved in GO:0034338 short-chain carboxylesterase activity
The following genes and proteins are representative of enzymes and systems that exhibit or are studied in relation to short-chain carboxylesterase activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MarCE | Marine carboxylesterase with synthetic ester-degrading activity | Model for environmental ester degradation and biocatalysis |
| Artificial self-assembling peptide | Minimal enzyme with short-chain carboxylesterase activity | Proof-of-concept for designed esterases |
| CES1 | Human carboxylesterase 1, hydrolyzes short-chain esters | Drug metabolism and lipid homeostasis |
| CES2 | Human carboxylesterase 2, hydrolyzes short-chain esters | Prodrug activation and xenobiotic metabolism |
| PLA2G | Phospholipase A2 family, ester cleavage in phospholipids | Inflammatory signaling and venom toxicity |
| Nrf2 | Transcription factor regulating antioxidant and metabolic genes | Modulates esterase expression in liver disease models |
| TRPV1 | Ion channel in neuroimmune crosstalk | Links lipid mediators to asthma exacerbation |
| Lipase (industrial) | Long-chain ester hydrolysis, inactivated by short-chain alcohols | Contrasts with short-chain specificity |
| Butyrylcholinesterase | Serine hydrolase with butyrate esterase activity | Classic example of short-chain esterase activity |
| Acetylcholinesterase | Serine hydrolase with short-chain esterase activity | Neurotransmission and inhibitor studies |
| Liver carboxylesterases | Hepatic hydrolysis of short-chain esters | Nonalcoholic steatohepatitis models |
| Gut microbiota esterases | Microbial short-chain ester hydrolysis | Gut-lung axis and asthma models |
| Lysosomal phospholipase A2 | Lysosomal ester hydrolysis | Lysosomal storage and lipid signaling |
| Carnitine acyltransferases | Acyl transfer with short-chain acyl groups | Mitochondrial fatty acid oxidation |
| Scorpion venom PLA2 | Ester hydrolysis in venom | Toxin mechanism studies |
| Marine metagenome esterases | Environmental short-chain ester hydrolysis | Biocatalyst discovery |
| Synthetic ester substrates | p-Nitrophenyl butyrate and related esters | Standard activity assays |
How Is short-chain carboxylesterase activity Regulated?
Short-chain carboxylesterase activity is regulated at multiple levels. Transcriptionally, genes encoding these enzymes can be induced by xenobiotics, oxidative stress and metabolic signals; for example, Nrf2 activation alters the expression of detoxification and metabolic enzymes in experimental steatohepatitis. Post-translationally, serine hydrolase activity is controlled by covalent inhibitors and by proteolytic processing. Substrate availability and product inhibition also modulate flux through the reaction, and short-chain alcohols can inactivate related lipases through two distinct mechanisms. In microbial communities, esterase expression responds to environmental ester availability and stress.
short-chain carboxylesterase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CES1 | Drug metabolism and lipid homeostasis | Knockout and overexpression cell models |
| CES2 | Prodrug activation and xenobiotic metabolism | Point-mutation models of catalytic serine |
| PLA2G | Inflammatory signaling and asthma | Knockout and knock-in models |
| Nrf2 | Nonalcoholic steatohepatitis and liver fibrosis | Pharmacologic activation and knockout models |
| MarCE | Environmental ester degradation | Overexpression in microbial hosts |
Metabolic and liver disease
Short-chain carboxylesterase activity contributes to the hydrolysis of endogenous and xenobiotic esters in the liver. Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacologic activation of Nrf2, which regulates antioxidant and metabolic genes including esterases. Dysregulated ester hydrolysis can alter lipid signaling and contribute to hepatic steatosis and inflammation.
Inflammatory and immune disorders
Lipid mediators generated by ester hydrolysis participate in inflammatory signaling. Lysosomal phospholipase A2, a related esterase, is involved in lipid metabolism and immune regulation. Gut-lung axis studies show that microbiota dysbiosis-coordinated PLA2-TRPV1 neuroimmune crosstalk exacerbates nanoplastic-induced asthma, linking esterase-related lipid mediators to airway inflammation.
Drug metabolism and toxicity
Human carboxylesterases hydrolyze ester-containing drugs and prodrugs, influencing their pharmacokinetics and toxicity. Altered short-chain carboxylesterase activity can therefore change drug exposure and contribute to interindividual variability in drug response. Understanding these enzymes is important for prodrug design and for predicting drug-drug interactions.
From short-chain carboxylesterase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the candidate gene essential for short-chain ester hydrolysis? | CRISPR knockout cell line |
| Does a specific catalytic residue mediate activity? | Point-mutation knock-in of catalytic serine |
| Can a tagged enzyme be used for localization studies? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression increase ester hydrolysis capacity? | Overexpression cell model |
| Which substrates are preferred by the enzyme? | In vitro activity assay with p-nitrophenyl esters |
| Does the enzyme contribute to disease phenotypes? | Disease-relevant knockout or knock-in models |
How to Study the short-chain carboxylesterase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| p-Nitrophenyl butyrate assay | Hydrolysis rate of short-chain ester | Enzyme kinetics and inhibitor testing |
| Activity-based protein profiling | Active serine hydrolases in proteomes | Discovery of new esterases |
| RNA sequencing | Expression of carboxylesterase genes | Response to Nrf2 activation or stress |
| Metagenomics | Diversity of esterase genes in environment | Biocatalyst discovery |
| X-ray crystallography | Three-dimensional structure of enzyme | Active-site mapping |
| Molecular docking | Predicted substrate binding | Specificity engineering |
| CRISPR knockout screening | Gene essentiality for ester hydrolysis | Functional genomics |
| Western blotting | Protein expression levels | Validation of overexpression or knockout |
Enzymatic activity assays
Short-chain carboxylesterase activity is typically measured using chromogenic substrates such as p-nitrophenyl butyrate, where hydrolysis releases p-nitrophenol that can be quantified spectrophotometrically. The artificial self-assembling peptide with carboxylesterase activity was characterized using this approach, demonstrating strict specificity for short-chain esters. Marine carboxylesterase MarCE was similarly assayed for synthetic ester-degrading activity.
Proteomics and activity-based protein profiling
Activity-based protein profiling using serine hydrolase probes can identify enzymes with short-chain carboxylesterase activity in complex proteomes. Mass spectrometry-based proteomics can quantify enzyme abundance and post-translational modifications. These methods are useful for discovering new esterases and for validating CRISPR-engineered cell lines.
Transcriptomics and metagenomics
RNA sequencing can reveal expression changes in carboxylesterase genes under different conditions, such as Nrf2 activation in steatohepatitis models. Metagenomic and metatranscriptomic analyses of environmental samples can identify novel short-chain carboxylesterase genes from microbial communities. These approaches help link genotype to function in diverse ecosystems.
Structural and computational methods
X-ray crystallography, NMR and molecular docking can reveal the acyl-binding pocket and catalytic triad of short-chain carboxylesterases. Computational modeling of substrate binding can predict chain-length specificity and guide enzyme engineering. These methods complement biochemical assays and CRISPR-based functional studies.
How CRISPR Can Be Used to Study GO:0034338 short-chain carboxylesterase activity
Knockout
CRISPR knockout of candidate short-chain carboxylesterase genes can abolish enzymatic activity and reveal loss-of-function phenotypes. For example, knocking out MarCE in a marine bacterium would test its role in synthetic ester degradation. In mammalian cells, knockout of CES1 or CES2 can assess their contribution to drug metabolism.
Point Mutation
Point mutation of the catalytic serine or other triad residues can distinguish enzyme activity from scaffolding functions. CRISPR-mediated point mutation can introduce a single amino acid substitution that inactivates short-chain carboxylesterase activity while preserving protein expression. This is useful for separating catalytic from non-catalytic roles.
Knock-in
Knock-in of a tagged or reporter allele allows visualization and purification of the enzyme without altering its catalytic activity. CRISPR knock-in can also introduce disease-associated mutations or regulatory elements to study expression control. Tagged knock-in models are valuable for localization and interaction studies.
Overexpression
CRISPR activation or cDNA overexpression can increase short-chain carboxylesterase activity to test gain-of-function effects. Overexpression of MarCE in a heterologous host can enhance ester degradation and provide a platform for biocatalysis. In mammalian cells, overexpression of CES1 or CES2 can increase prodrug activation.
How EDITGENE Supports short-chain carboxylesterase activity Research
Researchers studying short-chain carboxylesterase activity-related genes often need to determine whether a candidate gene is causally involved in ester hydrolysis, metabolic regulation or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for short-chain carboxylesterase activity research.
Frequently Asked Questions About short-chain carboxylesterase activity
What is short-chain carboxylesterase activity?
Short-chain carboxylesterase activity (GO:0034338) is a molecular function that catalyzes the hydrolysis of carboxylic esters into an alcohol and a carboxylic anion, where the carboxylic chain has 8 or fewer carbon atoms.
What genes are involved in short-chain carboxylesterase activity?
Genes encoding serine hydrolases such as CES1, CES2, MarCE and artificial carboxylesterase peptides are representative examples.
What is the GO ID for short-chain carboxylesterase activity?
The Gene Ontology ID is GO:0034338.
What are the synonyms for short-chain carboxylesterase activity?
Synonyms include butyrate esterase activity, butyryl esterase activity, methylbutyrase activity, methylbutyrate esterase activity, monobutyrase activity, propionyl esterase activity and short-chain esterase activity.
How is short-chain carboxylesterase activity measured?
It is commonly measured using chromogenic substrates such as p-nitrophenyl butyrate, which releases p-nitrophenol upon hydrolysis.
What is the difference between short-chain carboxylesterase and lipase activity?
Short-chain carboxylesterases prefer acyl chains of 8 or fewer carbons, whereas lipases typically act on long-chain triglycerides.
Which diseases are linked to short-chain carboxylesterase activity?
Altered activity has been associated with metabolic and liver disease, inflammatory conditions and variable drug metabolism.
Can CRISPR be used to study short-chain carboxylesterase activity?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models are widely used to study the function of these enzymes.
What substrates do short-chain carboxylesterases prefer?
They prefer short-chain p-nitrophenyl esters such as p-nitrophenyl butyrate and related compounds.
Where can I find reliable data on GO:0034338?
The QuickGO database provides the authoritative definition and synonyms for GO:0034338, and PubMed literature provides experimental evidence.
Conclusion
GO:0034338 short-chain carboxylesterase activity defines a fundamental enzymatic function that cleaves short-chain carboxylic esters and is conserved across diverse organisms. Its study has implications for biotechnology, drug metabolism and inflammatory disease, and CRISPR-based models are powerful tools for establishing causal roles of candidate genes. Continued research on this activity will advance both basic enzymology and translational applications.
References
- 1. Bremer J. 1983. Carnitine--metabolism and functions.. Physiol Rev 63(4):1420-80 PMID: 6361812
- 2. Shayman JA et al.. 2019. Lysosomal phospholipase A2.. Biochim Biophys Acta Mol Cell Biol Lipids 1864(6):932-940 PMID: 30077006
- 3. Sharma RS et al.. 2018. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).. Cell Mol Gastroenterol Hepatol 5(3):367-398 PMID: 29552625
- 4. Liu Y et al.. 2022. An artificial self-assembling peptide with carboxylesterase activity and substrate specificity restricted to short-chain acid p-nitrophenyl esters.. Front Chem 10:996641 PMID: 36199662
- 5. Krayem N et al.. 2020. Scorpion venom phospholipases A(2): A minireview.. Toxicon 184:48-54 PMID: 32473923
- 6. Mangiagalli M et al.. 2022. Short-chain alcohols inactivate an immobilized industrial lipase through two different mechanisms.. Biotechnol J 17(6):e2100712 PMID: 35188703
- 7. Zeng X et al.. 2026. Gut-lung axis: a novel mechanism involving microbiota dysbiosis-coordinated PLA2-TRPV1 neuroimmune crosstalk in nanoplastic-induced asthma exacerbation.. Environ Int 207:110047 PMID: 41512508
- 8. Carr CM et al.. 2024. Identification and expression of MarCE, a marine carboxylesterase with synthetic ester-degrading activity.. Microb Biotechnol 17(6):e14479 PMID: 38881500
